Why the study?
Obesity predisposes to cardiovascular events and increases mortality, prompting a comprehensive evaluation of the protective effect of bariatric surgery on disease-specific mortality and major adverse cardiovascular events in patients with severe obesity.
Does bariatric surgery reduce disease-specific mortality and major adverse cardiovascular events in patients with severe obesity?
Does bariatric surgery reduce disease-specific mortality and major adverse cardiovascular events in patients with severe obesity?
Bariatric surgery significantly reduces cardiovascular mortality and major adverse cardiovascular events in patients with severe obesity, with greater mortality benefit seen in those with concurrent type 2 diabetes.
Answers are grounded in this paper and cite their sources.
May support bariatric surgery for CV risk reduction in severe obesity; extends observational meta-analytic evidence but requires RCTs.
Background: Obesity is associated with a significant predisposition towards cardiovascular events and acts as an important risk factor for mortality. Herein, we conducted a comprehensive meta-analysis to estimate the protective effect of bariatric surgery on disease-specific mortality and major adverse cardiovascular events (MACEs) in patients with severe obesity. Methods: PubMed and Embase were searched from inception to 4 June 2022. Eligible studies were age, sex, and BMI-matched cohort studies. The protocol for this meta-analysis was registered on PROSPERO (ID: CRD42022337319). Results: Forty matched cohort studies were identified. Bariatric surgery was associated with a lower risk of disease-specific mortality including cancer mortality [hazard ratio with 95% confidence interval: 0.46 (0.37–0.58)], cardiovascular mortality [0.38 (0.29–0.50)], and diabetes mortality [0.25 (0.11–0.57)]. Bariatric surgery was associated with a lower incidence of MACEs [0.58 (0.51–0.66)] and its components including all-cause mortality [0.52 (0.47–0.58)], atrial fibrillation [0.79 (0.68–0.92)], heart failure [0.52 (0.42–0.65)], myocardial infarction [0.55 (0.41–0.74)], and stroke [0.75 (0.63–0.89)]. According to subgroup analysis on all-cause mortality, patients with severe obesity and type 2 diabetes benefited more from bariatric surgery than those with severe obesity only (heterogeneity between groups: P =0.001), while different surgical approaches brought similar benefits (heterogeneity between groups: P =0.87). Conclusions: This meta-analysis of 40 matched cohort studies supports that bariatric surgery reduces disease-specific mortality and incidence of both MACEs and its components in patients with severe obesity compared with nonsurgical subjects. Bariatric surgery deserves a more aggressive consideration in the management of severe obesity.
No takes yet. Share an insight, caveat, or question.
Cui et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: